Influenza Flashcards

1
Q

what type of virus is influenza

A

ssRNA, enveloped, helical nucleocapsid, 8 segment genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

surface antigens on influenza

A

A or B, H (hemagglutinin), and N (neuraminidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

antigenic drift

A

minor antigenic changes based on random mutations of either hemagglutinin or neuraminidase, cause epidemics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antigenic shift

A

reassortment of segments of viral genome which lead to a new virus to which the population has no immunity, cause pandemics, more deadly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why did mostly young people get effected by H1N1 in 2009

A

the H1N1 flu subtype had previously come in the early 1920s (Spanish flu) and the 70’s (Russian flu), so a lot of the older population had already developed immunity to it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how do viruses get deposited on respiratory tract

A

inhaled, attach to epithelium, penetrate columnar epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what safeguards are in place to prevent the attachment of pathogens to the epithelial lining of the respiratory tract

A

specific secretory antibodies IgA, nonspecific mucoproteins, mechanical ciliary action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

viral infection leads to viral replication leads to cell death leads to

A

release of the virus, initiating infection of the adjacent cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

incubation period of influenza virus

A

1-4 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

illness duration of influenza virus

A

2-5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

viral shedding

A

1 day before symptoms, for a total of 6 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

transmission of influenza virus

A

large droplet, close contact with infected person, can only travel 6 feet, possible small respiratory or from fomites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

fomites

A

inanimate objects that serve as a vector for infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clinical symptoms of influenza

A

fever, chills, headaches, myalgia, malaise, anorexia, dry cough, sore throat, nasal congestion/discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

length of systemic system persistance

A

3 days, typical duration of fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pulmonary complications of influenza

A

pneumonia, croup, COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

non-pulmonary complications of influenza

A

myositis, cardiac (toxic shock), guillain-barre (influenza A), transverse myelitis, encephalitis, Reye syndrome (aspirin in children)

18
Q

real-time PCR test

A

most sensitive and specific, but low availability and long wait for results

19
Q

RA rapid antigen detection

A

used in ER, takes 10-20 minutes, but only has a sensitivity around 60%, so you get a lot of false negatives; if you get a negative, you should probably double check with RA

20
Q

M2 blockers

A

work by blocking uncaring by amantadine

21
Q

neuraminidase inhibitors

A

prevent the release of the virus through exocytosis by oseltamivir (tamiflu) and zanamivir

22
Q

early antiviral treatment can

A

shorten illness/fever duration, reduce death, shorten hospitalization in children

23
Q

when to start antiviral treatment

A

within 48 hours of symptom onset

24
Q

who do you give antiviral treatment as early as possible to when influenza is suspected

A

hospitalized patients, severely ill patients at high risk for complications, complicated/progressive comorbidities

25
what drugs are the M2 blockers
rimantadine and amantadine
26
what drugs are the neuraminidase inhibitors
oseltamivir, zanamavir, peramivir
27
rimantidine
blocks viral uncaring by blocking M2 proton channel, oral administration, treats influenza A, some GI intolerance and CNS effects
28
amantidine
blocks viral uncaring by blocking M2 proton channel, administered orally, treats influenza A
29
what virus strain do M2 blockers prevent
influenza A
30
Oseltamivir
tamiflu, pro-drug activated in gut and liver, inhibit neuraminidase, administered orally, treats influenza A and B, well-tolerated with some nausea and vomiting
31
Zanamivir
relenza, inhaled drug, inhibits neuraminidase, treats influenza A and B, bronchospasms occur in asthmatics, nausea, and diarrhea
32
Peramivir
Rapivab, IV admin, inhbiits neuraminidase, treats influenza A and B, causes diarrhea
33
when to use influenza prophylaxis
close contact with person who has confirmed/probably/suspected influenza IF high risk for complication, IF <48 hours since last contact, and IF contact within 24 hours of infections period (fever subsiding)
34
definition of "close contact"
cared for/lived with person with flu, high likelihood of contact with large droplets/body fluids, talked fact-to-face, intubated them, etc.
35
which populations qualify for the high dose vaccine
adults >65, kids 6-8 months require 2 doses if it's their first vaccine, and high risk individuals i.e. HIV positive, will get high-dose vaccine
36
common cold viruses
rhinovirus and respiratory syncytial virus
37
RSV is significant because
it is the most common cause of death from respiratory illness in young children, and the leading cause of death from respiratory illness in those >65
38
if the vaccine matches the circulating strain well, what's your risk reduction for developing flu that will lead to a dr. appointment
50% risk reduction
39
relative measure of effect
1-odds ratio x 100, so what are the odds those with the flu were vaccinated/what are the odds those without the flu were vaccinated 1-that x 100
40
number needed to treat
well matched: 37, not well matched: 77
41
hemagglutanin
binds sialic acid and promotes viral entry into the host cell
42
neuraminidase
promotes progeny virion release